Edition:
United States

Sierra Oncology Inc (SRRA.OQ)

SRRA.OQ on NASDAQ Stock Exchange Global Market

1.83USD
25 Apr 2018
Change (% chg)

$0.01 (+0.55%)
Prev Close
$1.82
Open
$1.82
Day's High
$1.85
Day's Low
$1.78
Volume
14,558
Avg. Vol
105,284
52-wk High
$4.09
52-wk Low
$1.11

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 0.00 -0.065
Sep '17 0.00 -0.191
Jun '17 0.00 -0.198
Mar '17 0.00 -0.260
FY 2016 Dec '16 0.00 -0.305
Sep '16 0.00 -0.501
Jun '16 0.00 -0.426
Mar '16 0.00 -0.350
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 2 0.00 0.00 0.00 --
Quarter Ending Sep-18 2 0.00 0.00 0.00 --
Year Ending Dec-18 3 0.00 0.00 0.00 0.00
Year Ending Dec-19 3 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Jun-18 3 -0.21 -0.19 -0.23 --
Quarter Ending Sep-18 3 -0.22 -0.19 -0.23 --
Year Ending Dec-18 4 -0.79 -0.65 -0.88 -0.75
Year Ending Dec-19 4 -0.83 -0.68 -1.05 -0.71
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 178.44 32.31
P/E High - Last 5 Yrs. -- 280.78 46.12
P/E Low - Last 5 Yrs. -- 95.19 24.71
Beta -- 0.75 0.79
Price to Sales (TTM) -- 144.18 7.14
Price to Book (MRQ) 1.01 18.80 4.88
Price to Tangible Book (MRQ) 1.39 23.34 6.49
Price to Cash Flow (TTM) -- 117.05 24.37
% Owned Institutions 44.60 11.29 2.32

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.58
Dividend Yield - 5 Year Avg -- 0.20 0.78
Dividend 5 Year Growth Rate -- 1.96 4.08
Payout Ratio(TTM) -- 9.23 21.09

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 103.37 9.18
Sales (TTM) vs TTM 1 Yr. Ago -- 79.40 11.01
Sales - 5 Yr. Growth Rate -- 33.48 8.23
EPS (MRQ) vs Qtr. 1 Yr. Ago 78.68 -66.76 23.62
EPS (TTM) vs TTM 1 Yr. Ago 54.88 -- --
EPS - 5 Yr. Growth Rate -- 46.41 10.39
Capital Spending - 5 Yr. Growth Rate -- 44.90 10.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.70 2.52
Current Ratio (MRQ) 13.61 5.99 3.58
LT Debt to Equity (MRQ) 0.00 23.56 11.61
Total Debt to Equity (MRQ) 0.00 26.01 14.31
Interest Coverage (TTM) -- -183.16 30.88

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 31.78 54.20
Gross Margin - 5 Yr. Avg. -- 55.29 52.34
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -149.45 15.90
Operating Margin (TTM) -- -587.01 3.62
Operating Margin - 5 Yr. Avg. -- -161.52 11.17
Pre-Tax Margin (TTM) -- -560.40 4.27
Pre-Tax Margin - 5 Yr. Avg. -- -168.41 11.48
Net Profit Margin (TTM) -- -548.74 0.90
Net Profit Margin - 5 Yr. Avg. -- -168.67 7.81
Effective Tax Rate (TTM) -- -0.45 31.67
Effective Tax Rate - 5 Yr. Avg. -- 18.02 24.29

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 23,441,753 786,924,448
Net Income/Employee (TTM) -- 684,681 92,306,248
Receivable Turnover (TTM) -- 6.13 5.48
Inventory Turnover (TTM) -- 2.39 3.46
Asset Turnover (TTM) 0.00 0.40 0.87

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -32.66 -0.78 10.35
Return on Assets - 5 Yr. Avg. -- 0.53 11.38
Return on Investment (TTM) -35.17 -0.73 12.97
Return on Investment - 5 Yr. Avg. -- 3.99 14.74
Return on Equity (TTM) -35.17 -2.77 14.84
Return on Equity - 5 Yr. Avg. -- -0.21 16.08
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 55.92 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Sierra Oncology Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -12.08 -12.81 43 7
13 Week -44.00 -39.65 21 58
26 Week -4.21 -6.59 99 87
52 Week 31.88 18.85 99 78
YTD -51.21 -50.48 13 87
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 44.62%
# of Holders: 55
Total Shares Held: 31,856,867
3 Mo. Net Change: 258,753
# New Positions: 1
# Closed Positions: 0
# Increased Positions: 6
# Reduced Positions: 0
# Net Buyers: 6
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.